Commentary
DRACMA one year after: Which changes have occurred in diagnosis and treatment of CMA in Italy?
-
* Corresponding author: Alessandro Fiocchi allerg@tin.it
1 Paediatric Division, Department of Child and Maternal Medicine, University of Milan Medical School at the Melloni Hospital, (Via M. Melloni 52), Milan, (20129), Italy
2 Department of Clinical Epidemiology & Biostatistics, McMaster University Health Sciences Centre, (1280 Main Street West), Hamilton, (ON L8S 4K1), Canada
3 Italian Federation of Paediatric Medicine, Territorial Paediatric Primary Care Group (C.so Traiano 64/14), Turin, (10135), Italy
4 Allergy & Respiratory Diseases Clinic, Department of Internal Medicine, University of Genoa, (L.go R. Benzi, 10), Genoa, (16132), Italy
Italian Journal of Pediatrics 2011, 37:53 doi:10.1186/1824-7288-37-53
Published: 10 November 2011First paragraph (this article has no abstract)
In 2008 the World Allergy Organization (WAO) verified that the existing guidelines on CMA were usually national position papers reflecting local views and needs, with flexible, sometimes evidence-based, strategies [1-4]. Then, a global guideline for IgE-mediated CMA from diagnosis to treatment was developed using the GRADE approach [5]. We review here the first steps of Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA) together with the changes in diagnostic and therapeutic behavior generated by the new guideline.